As U.S. News tweaks methodology, top four cancer hospitals remain unchanged from last year (1) MD Anderson, (2) MSK, (3) Mayo, (4) DFCI

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Venkata Lokesh BattulaClinton YamA multidisciplinary team of researchers at VCU Massey Comprehensive Cancer Center and MD Anderson Cancer Center has been awarded a $7.3 million grant from the U.S. Department of Defense to fund a novel clinical trial targeting one of the most aggressive and hard-to-treat forms of breast cancer: metastatic triple-negative breast cancer.

September 12, 2025

Vol.51 No.33

Clinical Roundup

New genetic biomarker flags aggressive brain tumors, Mayo Clinic study finds

Clinicians typically classify meningiomas—the most common type of brain tumor—into three grades, ranging from slow-growing to aggressive. But a new multi-institutional study suggests that appearances may be deceiving. If a tumor shows activity in a gene called telomerase reverse transcriptase, it tends to recur more quickly, even if it looks low-grade under the microscope.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

Natural killer cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from the University of Texas MD Anderson Cancer Center.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Cyclin A/B RxL inhibitors restore G1–S-checkpoint in treatment of small cell lung cancer, DFCI research shows

A new class of drug results in cancer cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint known as the G1/S checkpoint, according to research gathered by the Oser Lab at Dana-Farber Cancer Institute.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.

September 05, 2025

Vol.51 No.32

In Brief

Yi Rong appointed editor-in-chief of Journal of Applied Clinical Medical Physics

Yi Rong was appointed editor-in-chief of the American Association Of Physicists In Medicine’s Journal of Applied Clinical Medical Physics by the AAPM board of directors.

August 01, 2025

Vol.51 No.30

As U.S. News tweaks methodology, top four cancer hospitals remain unchanged from last year

(1) MD Anderson, (2) MSK, (3) Mayo, (4) DFCI

YOU MAY BE INTERESTED IN

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

New genetic biomarker flags aggressive brain tumors, Mayo Clinic study finds

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

Cyclin A/B RxL inhibitors restore G1–S-checkpoint in treatment of small cell lung cancer, DFCI research shows

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Yi Rong appointed editor-in-chief of Journal of Applied Clinical Medical Physics

Renew today!

Subscriber content

Never miss an issue!

Login